Valuation: GemPharmatech Co., Ltd.

Market Cap 9.21B 1.36B 1.19B 1.1B 1.01B 1.92B 131B 1.95B 13.18B 5.16B 64.21B 5.12B 5.01B 221B P/E 2026 *
49x
P/E 2027 * 38.8x
Enterprise Value 9.21B 1.36B 1.19B 1.1B 1.01B 1.92B 131B 1.95B 13.18B 5.16B 64.21B 5.12B 5.01B 221B EV / Sales 2026 *
9.65x
EV / Sales 2027 * 8.2x
Free-Float
40.01%
Yield 2026 *
0.84%
Yield 2027 * 1.38%
1 day-2.93%
1 week-11.55%
Current month-6.94%
1 month+17.72%
3 months+19.41%
6 months+24.15%
Current year+46.61%
1 week 21.61
Extreme 21.61
31
1 month 18.14
Extreme 18.14
31
Current year 12.89
Extreme 12.89
31
1 year 12.89
Extreme 12.89
31
3 years 9.08
Extreme 9.08
31
5 years 9.08
Extreme 9.08
35.87
10 years 9.08
Extreme 9.08
35.87
Manager TitleAgeSince
Chief Executive Officer 45 2017-12-31
Director of Finance/CFO 43 2023-10-18
Chief Tech/Sci/R&D Officer 42 2017-12-31
Director TitleAgeSince
Chairman 62 2017-12-28
Director/Board Member 45 2017-12-31
Director/Board Member 62 2018-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-2.93%-11.55%+49.44%+22.86% 1.4B
-0.49%-3.58%-0.84%+2.13% 49.18B
-3.10%-3.47%+370.99%+567.62% 39.58B
-0.46%+3.98%+5.44%+60.79% 34.69B
-1.14%-1.90%+26.94%-9.56% 34.42B
-1.82%-1.48%+0.52%+32.02% 27.11B
-3.54%-6.91% - - 16.21B
-1.82%-1.91%+69.28%+112.51% 15.36B
+1.17%+3.10%+15.87%+16.79% 14.05B
-2.25%-0.92%+15.77%-32.78% 13.02B
Average -1.64%-1.01%+61.49%+85.82% 24.5B
Weighted average by Cap. -1.44%-0.42%+75.75%+117.07%

Financials

2026 *2027 *
Net sales 955M 141M 124M 114M 105M 199M 13.62B 202M 1.37B 535M 6.65B 530M 519M 22.96B 1.12B 166M 145M 134M 124M 234M 16.03B 238M 1.61B 629M 7.83B 624M 611M 27.02B
Net income 189M 27.92M 24.42M 22.57M 20.75M 39.23M 2.69B 39.91M 270M 106M 1.32B 105M 103M 4.54B 238M 35.24M 30.82M 28.49M 26.19M 49.52M 3.4B 50.38M 341M 133M 1.66B 132M 129M 5.73B
Net Debt - -
Logo GemPharmatech Co., Ltd.
GemPharmatech Co Ltd is a China-based company primarily engaged in the research and development, creation, production, sales and related technical services of experimental animal models. The Company’s main products include knockout and conditional knockout mouse models, immunodeficient mouse models, humanized mouse models, disease mouse models, germ-free mouse models and other products. The Company is also engaged in providing custom model generation, custom breeding, one-stop functional efficacy analysis services, and one-stop services from target concept verification to investigational new drug (IND) submission. The Company conducts its business in the domestic and overseas markets.
Employees
1,590
Date Price Change Volume
26-07-20 CN¥22.52 -2.93% 19,962,698
26-07-17 CN¥23.20 -20.00% 21,712,427
26-07-16 CN¥29.00 +0.66% 27,484,277
26-07-15 CN¥28.81 +17.02% 24,051,594
26-07-14 CN¥24.62 +1.40% 8,547,318
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.52CNY
Average target price
27.96CNY
Spread / Average Target
+24.16%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 688046 Stock